|
Meanwhile, Vertex with 23,600,000 shares out moves ahead to $50.50, with a market cap of some $1,200,000,000...even though it is a year plus from its protease launch and does not control the potential income like AGPH...and AGPH, with 13,500,000 shares out at $80 is currently valued at $1,100,000,000....The "market" is nervous and a bit strung out by the wait...The series of "rumors" for the decline are masks for anxiey...As a long time holder, these rides are unnerving but inherent to this company's recent history...Lind, by the way, had a 12 month target of $140... |
